chrX-152451236-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000808.4(GABRA3):c.-117A>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.73 ( 21039 hom., 23265 hem., cov: 22)
Exomes 𝑓: 0.80 ( 18 hom. 67 hem. )
Failed GnomAD Quality Control
Consequence
GABRA3
NM_000808.4 5_prime_UTR
NM_000808.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0520
Publications
5 publications found
Genes affected
GABRA3 (HGNC:4077): (gamma-aminobutyric acid type A receptor subunit alpha3) GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. [provided by RefSeq, Jul 2008]
GABRA3 Gene-Disease associations (from GenCC):
- epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic featuresInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Illumina
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant X-152451236-T-G is Benign according to our data. Variant chrX-152451236-T-G is described in ClinVar as Benign. ClinVar VariationId is 1241796.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.705 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.729 AC: 79544AN: 109076Hom.: 21046 Cov.: 22 show subpopulations
GnomAD3 genomes
AF:
AC:
79544
AN:
109076
Hom.:
Cov.:
22
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.804 AC: 115AN: 143Hom.: 18 Cov.: 0 AF XY: 0.848 AC XY: 67AN XY: 79 show subpopulations
GnomAD4 exome
AF:
AC:
115
AN:
143
Hom.:
Cov.:
0
AF XY:
AC XY:
67
AN XY:
79
show subpopulations
African (AFR)
AF:
AC:
1
AN:
2
American (AMR)
AF:
AC:
1
AN:
3
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
1
East Asian (EAS)
AF:
AC:
4
AN:
5
South Asian (SAS)
AF:
AC:
0
AN:
1
European-Finnish (FIN)
AF:
AC:
2
AN:
2
Middle Eastern (MID)
AF:
AC:
2
AN:
2
European-Non Finnish (NFE)
AF:
AC:
102
AN:
122
Other (OTH)
AF:
AC:
2
AN:
5
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome Data not reliable, filtered out with message: InbreedingCoeff AF: 0.729 AC: 79544AN: 109125Hom.: 21039 Cov.: 22 AF XY: 0.727 AC XY: 23265AN XY: 31997 show subpopulations
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
AC:
79544
AN:
109125
Hom.:
Cov.:
22
AF XY:
AC XY:
23265
AN XY:
31997
show subpopulations
African (AFR)
AF:
AC:
16320
AN:
29470
American (AMR)
AF:
AC:
7931
AN:
10409
Ashkenazi Jewish (ASJ)
AF:
AC:
2108
AN:
2617
East Asian (EAS)
AF:
AC:
1812
AN:
3395
South Asian (SAS)
AF:
AC:
1641
AN:
2491
European-Finnish (FIN)
AF:
AC:
4715
AN:
5824
Middle Eastern (MID)
AF:
AC:
157
AN:
212
European-Non Finnish (NFE)
AF:
AC:
43181
AN:
52548
Other (OTH)
AF:
AC:
1067
AN:
1484
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
732
1463
2195
2926
3658
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
672
1344
2016
2688
3360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 28, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.